Should we wait or not? The preferable option for patients with stage IV oral cancer in COVID-19 pandemic

Atanu Bhattacharjee, Vijay M Patil, Rajesh Dikshit, Kumar Prabhash, Arjun Singh, Pankaj Chaturvedi (Lead / Corresponding author)

Research output: Contribution to journalArticlepeer-review

9 Citations (Scopus)

Abstract

Background
The coronavirus infection is rapidly spreading, putting a strain on health care services across the globe. Patients with oral cancer are susceptible often immunosuppressed due to the disease and/or the treatment received.
Methods
We performed a simulation of the currently available data using a multistate and hazards model to provide an objective model for counseling and decision making for health care workers.
Results
Stage IV patients with oral cancer who did not receive treatment had progression of disease and an increased mortality rate compared to patients who receive treatment but did not contract COVID-19. The patients who received treatment and got affected with COVID-19 had a far worse impact and higher mortality rate than all other groups.
Conclusion
Isolation and deferring treatment for stage IV patients with oral cancer, so as to avoid hospital visits and contraction of COVID-19, is an advisable strategy based on this model.
Original languageEnglish
Pages (from-to)1173-1178
Number of pages6
JournalHead & Neck
Volume42
Issue number6
Early online date28 Apr 2020
DOIs
Publication statusPublished - 27 May 2020

Keywords

  • cancer
  • coronavirus
  • COVID-19
  • simulation

Fingerprint

Dive into the research topics of 'Should we wait or not? The preferable option for patients with stage IV oral cancer in COVID-19 pandemic'. Together they form a unique fingerprint.

Cite this